These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
357 related items for PubMed ID: 20956468
21. Can Carrier-Mediated Delivery System Promote the Development of Antisense Imaging? Liu CB, Xu JQ, Xu BX, Zhang JM, Chen YM, Wang RM, Tian JH. Mol Imaging Biol; 2015 Oct; 17(5):625-32. PubMed ID: 25666290 [Abstract] [Full Text] [Related]
22. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer. Xiong J, Yang Q, Li J, Zhou S. Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365 [Abstract] [Full Text] [Related]
23. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Wang H, Nan L, Yu D, Agrawal S, Zhang R. Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884 [Abstract] [Full Text] [Related]
24. Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes. Ren BX, Yang F, Zhu GH, Huang ZX, Ai H, Xia R, Liu XJ, Lu M, Song B. Cancer Sci; 2012 Aug; 103(8):1434-9. PubMed ID: 22534012 [Abstract] [Full Text] [Related]
25. Improved Cellular Delivery of Antisense Oligonucleotide for miRNA-21 Imaging In Vivo Using Cell-Penetrating Peptide-Based Nanoprobes. Yang G, Zhao Y, Gong A, Miao W, Yan L, Nie P, Wang Z. Mol Pharm; 2021 Mar 01; 18(3):787-795. PubMed ID: 33480702 [Abstract] [Full Text] [Related]
26. Noninvasive visualization of microRNA-155 in multiple kinds of tumors using a radiolabeled anti-miRNA oligonucleotide. Kang L, Huo Y, Ji Q, Fan S, Yan P, Zhang C, Ma H, Hao P, Sun H, Zheng Z, Xu X, Wang R. Nucl Med Biol; 2016 Feb 01; 43(2):171-8. PubMed ID: 26872442 [Abstract] [Full Text] [Related]
27. Antisense imaging of colon cancer-bearing nude mice with liposome-entrapped 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA. Zheng JG, Tan TZ. World J Gastroenterol; 2004 Sep 01; 10(17):2563-6. PubMed ID: 15300907 [Abstract] [Full Text] [Related]
35. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F. Bioconjug Chem; 2007 Mar 01; 18(2):438-46. PubMed ID: 17341108 [Abstract] [Full Text] [Related]
36. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs]. Fan C, Hnatowich DJ. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun 01; 25(3):712-5. PubMed ID: 18693462 [Abstract] [Full Text] [Related]
37. A novel 99mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot study. Zhao Q, Yan P, Wang RF, Zhang CL, Li L, Yin L. PLoS One; 2013 Jun 01; 8(4):e61043. PubMed ID: 23573294 [Abstract] [Full Text] [Related]
38. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. Wang H, Yu D, Agrawal S, Zhang R. Prostate; 2003 Feb 15; 54(3):194-205. PubMed ID: 12518324 [Abstract] [Full Text] [Related]